Navigation Links
Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients.
Date:4/1/2009

- Journal of Neuroscience paper describes role of Zinc in developing Alzheimer's -

MELBOURNE, Australia, April 1 /PRNewswire-FirstCall/ -- Prana Biotechnology (ASX:PBT; Nasdaq: PRAN) today announced that an independent study conducted by researchers at the University of California, Irvine, validates Prana's fundamental drug strategy for Alzheimer's Disease in blocking the toxic interaction between Abeta and brain metals, such as zinc, that damages synapses and cause cognitive loss.

The study, published in the Journal of Neuroscience showed that the release of zinc from synapses is critical for Abeta to form oligomers and to aggregate. Dr Glabe, an author of the paper, noted, "These results are very exciting news for understanding the mechanism of Alzheimer pathogenesis. They help elucidate the fundamental role of metal ions like zinc in causing the formation of Abeta oligomers which damage synapses".

Prana's lead Alzheimer's disease compound, PBT2, targets a toxic form of the Abeta protein in the synapses of the brain by inhibiting the interaction between Abeta and zinc. The findings provide an explanation as to how PBT2 has demonstrated the ability to restore normal function to Abeta-impaired synapses and so reverse cognitive loss in animal models of AD. PBT2 has completed a Phase IIa study in Alzheimer's disease patients, demonstrating a lowering of Abeta levels in the CSF and signs of cognitive improvement within three months.

Commenting on the significance of these findings Dr Jeffrey Cummings of UCLA, and Chair of Prana's Scientific Advisory Board, noted that, "the role of Abeta oligomers in damaging synapses resulting in cognitive impairment is well established in the literature. What has been less clear is why oligomers congregate at the synapse. The work by Dr. G
'/>"/>

SOURCE Prana Biotechnology
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom
5. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
6. Roche to Nominate Independent Directors for Election at Ventanas 2008 Annual Stockholders Meeting
7. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R)
8. Kiwa Fertilizers Pass Independent Tests
9. Amarin Appoints Dr. William Mason as Lead Independent Director
10. China Pharma Appoints Three Independent Non-Executive Directors
11. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Auckland, New Zealand (PRWEB) May 16, 2013 ... Zealand, was invited to speak to doctors in China about ... across Australia and NZ, this was her first trip to ... , Dr. Hart visited Guangzhou and Fuzhou, home to 12 ... treatments in China is very high at this point in ...
(Date:5/16/2013)... Mass. (PRWEB) May 16, 2013 Cambridge ... Summit from August 19-23, 2013 at the Renaissance Waterfront ... the Summit provide a close-up look at the current ... and ensuring bottom-line quality. Leaders in the field ... ways to produce biopharmaceuticals with greater specificity and efficiency. ...
(Date:5/16/2013)... Ore. , May 16, 2013  HealthSparq, ... many of the nation,s largest regional health plans, ... America,s Health Insurance Plans (AHIP) Institute 2013 conference ... highlight survey results showing how health insurance companies ... for the consumer and marketplace demands for increased ...
(Date:5/16/2013)... HAYWARD, Calif. , May 16, 2013 ... University, Beijing , and the ... www.magceutics.com ) have demonstrated a novel therapy for reversing ... brain magnesium levels, they find significant cognitive improvement in ... to demonstrate a mechanism for reversing cognitive decline for ...
Breaking Biology Technology:The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3
... ... ... ... ...
... ... production, Zap-Hybridoma improves target antibody purity and hybridoma productivity. , ... Fort Collins, CO (PRWEB) ... hybridoma cell culture. Zap-Hybridoma was created to improve monoclonal antibody productivity and ...
... ... announced today that Michelle Flewell, the company’s Vice President of eLearning ... to serve on the Certificate Accreditation Program Advisory Council. Flewell will ... with developing policies and procedures for ICE accreditation of assessment-based certificate ...
Cached Biology Technology:VIVUS to Present at Two Upcoming Investor Conferences 2VIVUS to Present at Two Upcoming Investor Conferences 3InVitria Optimizes Hybridoma Cell Culture with New Product Zap-Hybridoma 2InVitria Optimizes Hybridoma Cell Culture with New Product Zap-Hybridoma 3BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council 2BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council 3
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... 95th Annual Meeting in San Francisco, CA from ... promote the entry of students, postdoctorates and scientists ... basic science community and to encourage the participation ... Meeting. , Awards are given to poster/platform presenters ...
(Date:5/16/2013)... For decades, scientists have used ancient shorelines to predict the ... Markings of a high shoreline from three million years ago, ... period were thought to be evidence of a high ... This assumption has led many scientists to think that if ... they may do just the same in our modern, progressively ...
(Date:5/16/2013)... the cellular layer lining the body,s blood vessels, ... nanometers in thickness, this super-tenuous structure routinely withstands ... to create a unique and highly dynamic barrier ... from the body,s circulatory system. , It,s also ... be physically breached to enable immune cells ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... just 9.8 kilobases, the HIV genome pales in comparison ... primate targets. The compact retrovirus encodes just 14 proteins, ... virulence. As a retrovirus, HIV uses the host’s cellular ... RNA genome into DNA and infiltrate human chromosomal DNA. ...
... high-tech microscope will be brought to the marketplace, ... organisms. EMBLEM Technology Transfer GmbH (EMBLEM), the commercial ... announced today that it has signed a licensing ... a new technology called SPIM (Selective Plane Illumination ...
... a pretty good handle on how to teach human cells ... from the mouth's lining to form bone. , But in ... the jaw bone of a person undergoing radiation therapy for ... mouth as well as compensating for the damage of radiation. ...
Cached Biology News:Novel Enzyme Shows Potential As An Anti-HIV Target 2Novel Enzyme Shows Potential As An Anti-HIV Target 3The transparent organism: EMBLEM and Carl Zeiss give labs a unique look at life 2U-M scientist to talk about tissue engineering at AAAS 2